TYRA Trademark

Serial Number: 98529308

TYRA is a trademark filed by Tyra Biosciences, Inc. on May 1, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Tyra Biosciences, Inc.

2656 State Street
Carlsbad, CA 92008

Entity Type: 03

Legal Representation

Attorney of Record

Kevin M. Bovard

1,171 trademarks filed View all →

Correspondence Address

Kevin M. Bovard Baker & Hostetler LLP

1735 Market Street

Suite 3300

Philadelphia, PA 19103-7501

United States

Trademark Details

Filing Date

May 1, 2024

Registration Date

Not Registered

Published for Opposition

December 24, 2024

Goods & Services

providing medical information; providing medical information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; Providing a web site featuring medical information; Providing a website featuring information in the field of rare diseases, musculo-skeletal disorders, and skeletal dysplasia; providing information in the field of pharmaceuticals; providing medical information in the field of oncology; providing a website featuring information in the field of the diagnosis and treatment of cancer.

Research and development of drugs in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research for medical purposes in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; clinical research in the fields of oncology, rare diseases, musculo-skeletal disorders, and skeletal dysplasia; scientific research and development of pharmaceuticals for the treatment of cancer, rare diseases, musculo-skeletal disorders, and skeletal dysplasia.

pharmaceuticals for the treatment of rare genetic diseases; pharmaceuticals for the treatment of musculo-skeletal disorders; pharmaceuticals for the treatment of skeletal dysplasia; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of cells that are resistant to drugs; pharmaceuticals for the treatment and prevention of drug resistance; anti-cancer pharmaceuticals